Hospice Insights Podcast - Bottom Line, Top of Mind: Compliance Checklists for Hospice and Home Health
Podcast — Drug Pricing and Market Access: CMS Update With Rujul Desai
Hospice Insights Podcast - Hospice Audit Updates: UPICs May Pick You for a Prepayment Review
Podcast — Drug Pricing and Market Access: Highlights From Recent CMS and AHLA Conferences
Hospice Insights Podcast - High Risk Hospices Are in the Hot Seat Across Six States
McDonald Hopkins Legal Diagnosis Podcast, Episode 8: Stark Law
Hospice Insights Podcast - What’s New? CMS Provisional Period of Enhanced Oversight Application to “New” Hospices
State AGs in Action: Health Care Enforcement in 2026 – Speaking of Litigation Video Podcast
Hospice Insights Podcast - PPEO Playbook: The High-Stakes Game Hospices Can’t Afford to Lose
Got an Audit Letter? Here’s What Every Health Care Provider Should Do
Concierge Practices: Getting Started and Staying Compliant
Hospice Insights Podcast - Hospital to Hospice: Managing Referrals and Relationships
AGG Talks: Government Insight for Life Sciences Leaders | How Medicare Regulations Could Affect Access to Gender-Affirming Care: Implications for Life Sciences Companies
Hospice Insights Podcast - If Only I Knew… Avoiding the Most Common Mistakes with the 855
Exploring Long-Term Home Care Solutions with Albert Eshoo & Joyce Barocas
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 253: The Rise of Ambulatory Surgery Centers with Mark Wainner of ASCA
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 252: Navigating Policy and Technology Shifts in MedTech with Bobby Patrick of AdvaMed
Hospice Insights Podcast - Let’s Face (to Face) It: Important Changes to Hospice Face-to-Face Attestation Requirements and Other Tidbits from the 2026 Hospice Final Rule
Hospice Insights Podcast - Hospice Audit Updates: Hospices Fare Well in Federal Court
HHS OIG’s Nursing Facility: Industry Segment-Specific Compliance Program Guidance
The Department of Justice (“DOJ”) continues to expand its aggressive health care fraud enforcement efforts with the announcement of a new West Coast Health Care Fraud Strike Force....more
The Office of the Inspector General (OIG) continues to focus on Medicare Advantage (MA) risk adjustment payments, issuing a report this week detailing its audit of MA risk adjustment payments based on acute stroke diagnosis...more
On May 27, 2026, the Department of Justice (DOJ) announced a False Claims Act settlement with psychiatric hospital operator Oglethorpe Inc. (Oglethorpe) and three executives resolving allegations that they violated the False...more
The current U.S. administration’s most-favored-nation (MFN) drug pricing initiative raises numerous legal questions for life sciences companies that intend to sell drugs in the U.S. and abroad....more
News Briefs - March Hospital Operating Margins Rebounded, Data Show - Hospitals are showing signs of stronger operational discipline in early 2026, but those gains have yet to translate into meaningful financial growth. While...more
On May 28, 2026, CMS published a final rule (Final Rule) updating and revising the Increasing Organ Transplant Access Model (the IOTA Model) for Performance Year (PY) 2 (and future performance years). The Final Rule, which...more
The Department of Justice recently ramped up healthcare fraud investigations and prosecutions and shows no intention of slowing down. Indeed, the DOJ’s recent settlement with Oglethorpe, Inc. and its top executives offers key...more
The United States Department of Health and Human Services (“HHS”) announced at the end of May that it is expanding its use of AI to analyze the audit reports of states and other recipients of federal healthcare funding. This...more
On April 30, 2026, the Department of Justice (“DOJ”) announced the creation of the West Coast Health Care Fraud Strike Force, a coordinated enforcement initiative focused on healthcare fraud in Arizona, Nevada, and Northern...more
Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, Medicare, and state law....more
On May 20, the U.S. Department of Health and Human Services Office of Inspector General (OIG) published Advisory Opinion 26-11, concluding that it would not impose administrative sanctions against a precision oncology company...more
President Donald Trump signed into law H.R. 1 on July 4, 2025, major budget reconciliation legislation often referred to as the "One Big Beautiful Bill Act" (Pub. L. 119-21), but which the Centers for Medicare & Medicaid...more
The Centers for Medicare & Medicaid Services’ (CMS) guidance issued on April 2, 2026, addressing the Round 2028 Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program (Guidance)....more
The LEAD Model-Kidney Care’s Value-Based Care Journey LEADs Here - CMS’s LEAD Model marks the next evolution in valuebased kidney care, integrating CKD and ESRD patients into a primary care-centered ACO framework. As CKCC...more
News Briefs - High Court Won't Hear Drug Manufacturer Price Negotiation Appeal - The Supreme Court declined to hear an appeal from six drug manufacturers that wanted the court to reject the Medicare Drug Price Negotiation...more
Welcome back to the Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, we find out Virginia Governor Spanberger’s reasons for vetoing the retail cannabis market bill. A hemp...more
The US Department of Justice (DOJ) has announced a significant expansion of its health care fraud enforcement efforts with the formation of the West Coast Health Care Fraud Strike Force. This initiative is spearheaded by the...more
We are about to sit down to a large meal of Medicaid regs, many of which stem from requirements included in the One Big Beautiful Bill Act (OBBBA)....more
There have been a number of notable developments coming out of the U.S. Department of Health and Human Services Office of Inspector General (OIG). So today, we wanted to take a step back and do a 2026 look back on some of the...more
On May 14, 2026, the HHS Office of Inspector General (OIG) published a report finding that unclear Medicare requirements led to differing interpretations of inpatient rehabilitation facility (IRF) documentation, coverage, and...more
In 2026, the U.S. prescription drug market is predicted to exceed $1 trillion for the first time, and the growth of glucagon-like peptide-1 (GLP-1) drugs are one of the primary reasons. Driven by new regulatory changes and...more
In 2025, Congress passed a sweeping federal spending law widely referred to as the “One Big Beautiful Bill Act” (H.R. 1). Among its many provisions are significant changes to the Medicaid program, including the introduction...more
In hospice and home health, certain compliance problems can have a big impact on the organization’s bottom line—and ability to keep operating. Even seemingly minor issues can affect whether the organization will be fully paid...more
